tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

OPT Stock Latest News

Opthea Advances Retinal Disease Treatments
Company AnnouncementsOpthea Advances Retinal Disease Treatments
7d ago
6K
OPT
Opthea Advances nAMD Treatment with Sozinibercept
PremiumCompany Announcements
Opthea Advances nAMD Treatment with Sozinibercept
10d ago
6K
OPT
Opthea completes drug substance PPQ campaign for sozinibercept
PremiumThe Fly
Opthea completes drug substance PPQ campaign for sozinibercept
19d ago
OPT
Opthea Advances Toward Sozinibercept Commercialization
PremiumCompany Announcements
Opthea Advances Toward Sozinibercept Commercialization
19d ago
6K
OPT
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
23d ago
OPT
ABBV
Opthea price target lowered to $10 from $12 at Citi
PremiumThe FlyOpthea price target lowered to $10 from $12 at Citi
25d ago
OPT
Opthea to have presence at 24th EURETINA Congress
Premium
The Fly
Opthea to have presence at 24th EURETINA Congress
27d ago
OPT
Opthea’s Sozinibercept Eyes Breakthrough in AMD Therapy
Premium
Company Announcements
Opthea’s Sozinibercept Eyes Breakthrough in AMD Therapy
27d ago
6K
OPT
Opthea Prepares for Phase 3 Results with Leadership Revamp
PremiumCompany Announcements
Opthea Prepares for Phase 3 Results with Leadership Revamp
1M ago
6K
OPT
Opthea announces executive leadership changes and senior hires
PremiumThe Fly
Opthea announces executive leadership changes and senior hires
1M ago
OPT
Opthea Limited Showcases Innovations at Investor Conferences
PremiumCompany Announcements
Opthea Limited Showcases Innovations at Investor Conferences
1M ago
6K
OPT
Opthea price target lowered to $12 from $14 at H.C. Wainwright
PremiumThe Fly
Opthea price target lowered to $12 from $14 at H.C. Wainwright
1M ago
OPT
Opthea reports FY24 adjusted EPS ($27.27) vs. ($30.61) last year
PremiumThe FlyOpthea reports FY24 adjusted EPS ($27.27) vs. ($30.61) last year
1M ago
OPT
Opthea Limited: Revenues Up, Losses Widen
Premium
Company Announcements
Opthea Limited: Revenues Up, Losses Widen
1M ago
6K
OPT
Opthea Limited Showcases at Ophthalmology Event
Premium
Company Announcements
Opthea Limited Showcases at Ophthalmology Event
2M ago
6K
OPT
Opthea forms Medical Advisory Board with retinal disease experts
PremiumThe Fly
Opthea forms Medical Advisory Board with retinal disease experts
3M ago
OPT
Opthea completes 1 for 1.22 accelerated non-renounceable entitlement offer
PremiumThe Fly
Opthea completes 1 for 1.22 accelerated non-renounceable entitlement offer
3M ago
OPT
Opthea announces publication on VEGF-C, VEGF-D signaling pathways
PremiumThe Fly
Opthea announces publication on VEGF-C, VEGF-D signaling pathways
3M ago
OPT
Opthea’s Sozinibercept Shows Promise for Wet AMD
PremiumCompany Announcements
Opthea’s Sozinibercept Shows Promise for Wet AMD
3M ago
6K
OPT
Opthea looks to raise $150M via an $6.6M placement, $143.4M ANREO
PremiumThe FlyOpthea looks to raise $150M via an $6.6M placement, $143.4M ANREO
4M ago
OPT
Opthea Ltd (ADR) trading halted, news pending
Premium
The Fly
Opthea Ltd (ADR) trading halted, news pending
4M ago
OPT
Opthea completes enrollment in Phase 3 clinical program with sozinibercept
Premium
The Fly
Opthea completes enrollment in Phase 3 clinical program with sozinibercept
4M ago
OPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >